Trexquant Investment’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Trexquant Investment's ATRC Position: Q2 2026 in Review
Trexquant Investment reduced its AtriCure (ATRC) stake by 81% in Q2 2026, selling an estimated $3.27M and leaving 26,784 shares worth $749K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.
Trexquant Investment first reported a position in ATRC in Q1 2015 and has held it in 22 quarters since. The position peaked at $8.89M in Q1 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Trexquant Investment held 26,784 shares of AtriCure worth $749K as of Q2 2026.
- Trexquant Investment sold 116,310 AtriCure shares in Q2 2026, an estimated $3.27M.
- AtriCure made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1549 holding.
- Trexquant Investment first reported a position in AtriCure in Q1 2015 and has held it in 22 quarters since.
- Trexquant Investment's AtriCure position peaked at $8.89M in Q1 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.